Another way to kill off the population?
FDA expands recall of common drug used for cardiovascular problems because it contains trace amounts of an unexpected impurity known as N-nitrosodiethylamine (NDEA), a probable human carcinogen. Valsartan, an angiotensin receptor blocker or ARB, is the generic version of the brand name drugs Diovan and Prexxartan. It's often combined with other drugs and found other brand names. It's used for:
• Heart Attack
• Heart Failure
• High Blood Pressure
• Left Ventricular Dysfunction
The latest PDF of Recall list of Valsartan products - Updated as of December 31, 2018:
https://www.fda.gov/downloads/Drugs/DrugSafety/UCM615703.pdfutm_campaign=FDA%20updates%20on%20angiotensin%20II%20receptor%20blocker%20%28ARB%29%20recalls%3A%20Mylan%20expands&utm_medium=email&utm_source=Eloqua
——————————————-
https://www.upi.com/Health_News/2019/01/02/FDA-issues-new-recall-for-blood-pressure-meds-containing-valsartan/7781546453594/
FDA issues new recall for blood pressure meds containing valsartan
By Tauren Dyson
Jan. 2, 2019 / 3:06 PM
Jan. 2 (UPI) – A voluntary recall has been issued for a blood pressure medication due to concerns it contains small amounts of carcinogens called N-nitrosodiethylamine, or NDEA, which can cause cancer.
The latest recall, issued Monday, includes 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP – although the FDA said people "should continue taking their medication."
"The risk of harm to the patient's health may be higher if the treatment is stopped immediately with any alternative," the FDA said in the recall. "Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication."
The carcinogen is produced by several companies and has contaminated six blood pressure medications since November. All of them have since been recalled.
A December recall included 104 lots of three medicines: valsartan tablets, combination tablets with the drugs valsartan and amlodipine, and combination tablets with valsartan and hydrochlorothiazide.
The recall notice cautions anyone who's taken the drug to call a doctor but to continue taking the tablets until they find a substitute.
——————————–
FDA Announcement:
https://www.fda.gov/Safety/Recalls/ucm629213.htm
Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Consumer Level Recall of 80 Lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP, Due to the Detection of NDEA (N-Nitrosodiethylamine) Impurity
December 31, 2018
Aurobindo Pharma USA, Inc. is conducting a voluntary recall of 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP to the consumer level due to the detection of trace amounts of an unexpected impurity found in the finished drug product. The impurity detected in the finished drug product is N-nitrosodiethylamine (NDEA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification. To date, Aurobindo Pharma USA, Inc. has not received any reports of adverse events related to this recall.
Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP are indicated to control high blood pressure and for the treatment of heart failure. Patients who prescribed Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP should continue taking their medication, as the risk of harm to the patient’s health may be higher if the treatment is stopped immediately without any alternative treatment. Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication.
The products subject to recall are listed below and packaged in bottles. The product can be identified by checking the product name, manufacturer details and batch or lot number on the bottle containing these products [go to recall link shown above].
———————————–
Basic brand name/generic info on valsartan can be found at:
https://www.drugs.com/ingredient/valsartan.html
https://www.drugs.com/search.php?searchterm=valsartan